[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Radiopharmaceuticals in Nuclear Medicine Market Report 2017

October 2017 | 118 pages | ID: U2BB909F2BBEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Radiopharmaceuticals in Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine in these regions, from 2012 to 2022 (forecast).
United States Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers/players, with Radiopharmaceuticals in Nuclear Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bracco Imaging S.P.A.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Covidien, Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • GE Healthcare (Subsidiary Of General Electric Company)
  • IBA Group
  • Isotec, Inc. (Sigma-Aldrich)
  • Lantheus Medical Imaging, Inc.
  • Nordion, Inc.
  • Ntp Radioisotopes (Pty), Ltd.
  • Siemens Healthcare (Subsidiary Of Siemens AG)
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited
  • Rotem Industries, Ltd., Inc.
  • Australian Nuclear Association And Technology Organization (ANSTO)
  • Board of Radiation And Isotope Technology (BRIT)
  • Institute of Atomic Energy Polatom Radioisotope Centre
  • Institute of Isotopes Co., Ltd.
  • Institute Of Radioelement (IRE)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Diagnostic Radiopharmaceuticals
  • Therapy Radiopharmaceuticals
  • Enriched Stable Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including
  • Diagnostic Application
  • Therapeutic Application
  • Research
  • Pharmaceutical
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Radiopharmaceuticals in Nuclear Medicine Market Report 2017

1 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE OVERVIEW

1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Classification of Radiopharmaceuticals in Nuclear Medicine by Product Category
  1.2.1 United States Radiopharmaceuticals in Nuclear Medicine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Radiopharmaceuticals in Nuclear Medicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic Radiopharmaceuticals
  1.2.4 Therapy Radiopharmaceuticals
  1.2.5 Enriched Stable Isotopes
1.3 United States Radiopharmaceuticals in Nuclear Medicine Market by Application/End Users
  1.3.1 United States Radiopharmaceuticals in Nuclear Medicine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Diagnostic Application
  1.3.3 Therapeutic Application
  1.3.4 Research
  1.3.5 Pharmaceutical
  1.3.6 Other
1.4 United States Radiopharmaceuticals in Nuclear Medicine Market by Region
  1.4.1 United States Radiopharmaceuticals in Nuclear Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
  1.4.3 Southwest Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
  1.4.5 New England Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
  1.4.6 The South Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
  1.4.7 The Midwest Radiopharmaceuticals in Nuclear Medicine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Radiopharmaceuticals in Nuclear Medicine (2012-2022)
  1.5.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2022)
  1.5.2 United States Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2022)

2 UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Radiopharmaceuticals in Nuclear Medicine Average Price by Players/Suppliers (2012-2017)
2.4 United States Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
  2.4.1 United States Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
  2.4.2 United States Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Region (2012-2017)
3.2 United States Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Region (2012-2017)
3.3 United States Radiopharmaceuticals in Nuclear Medicine Price by Region (2012-2017)

4 UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2012-2017)
4.3 United States Radiopharmaceuticals in Nuclear Medicine Price by Type (2012-2017)
4.4 United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application (2012-2017)
5.2 United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bracco Imaging S.P.A.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cambridge Isotope Laboratories, Inc.
  6.2.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cardinal Health, Inc.
  6.3.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Covidien, Plc
  6.4.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eczacibasi-Monrol
  6.5.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Fujifilm Holdings Corporation
  6.6.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GE Healthcare (Subsidiary Of General Electric Company)
  6.7.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 IBA Group
  6.8.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Isotec, Inc. (Sigma-Aldrich)
  6.9.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Lantheus Medical Imaging, Inc.
  6.10.2 Radiopharmaceuticals in Nuclear Medicine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Nordion, Inc.
6.12 Ntp Radioisotopes (Pty), Ltd.
6.13 Siemens Healthcare (Subsidiary Of Siemens AG)
6.14 Taiyo Nippon Sanso Corporation
6.15 Urenco Limited
6.16 Rotem Industries, Ltd., Inc.
6.17 Australian Nuclear Association And Technology Organization (ANSTO)
6.18 Board of Radiation And Isotope Technology (BRIT)
6.19 Institute of Atomic Energy Polatom Radioisotope Centre
6.20 Institute of Isotopes Co., Ltd.
6.21 Institute Of Radioelement (IRE)

7 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS

7.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Forecast by Type (2017-2022)
11.3 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Forecast by Application (2017-2022)
11.4 United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Size (K Units) by Type (2012-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Radiopharmaceuticals Product Picture
Figure Therapy Radiopharmaceuticals Product Picture
Figure Enriched Stable Isotopes Product Picture
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Application in 2016
Figure Diagnostic Application Examples
Table Key Downstream Customer in Diagnostic Application
Figure Therapeutic Application Examples
Table Key Downstream Customer in Therapeutic Application
Figure Research Examples
Table Key Downstream Customer in Research
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) by Region (2012-2022)
Figure The West Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Players/Suppliers
Figure 2017 United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Players/Suppliers
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players/Suppliers
Figure 2017 United States Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players/Suppliers
Table United States Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 Players/Suppliers
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Radiopharmaceuticals in Nuclear Medicine Product Category
Table United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Region (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Region (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Types (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Type (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application (2012-2017)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2016
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2012-2017)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2012-2017)
Table Bracco Imaging S.P.A. Basic Information List
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Cambridge Isotope Laboratories, Inc. Basic Information List
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Cardinal Health, Inc. Basic Information List
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Covidien, Plc Basic Information List
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Eczacibasi-Monrol Basic Information List
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Fujifilm Holdings Corporation Basic Information List
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table GE Healthcare (Subsidiary Of General Electric Company) Basic Information List
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Isotec, Inc. (Sigma-Aldrich) Basic Information List
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Lantheus Medical Imaging, Inc. Basic Information List
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in United States (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in United States (2012-2017)
Table Nordion, Inc. Basic Information List
Table Ntp Radioisotopes (Pty), Ltd. Basic Information List
Table Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information List
Table Taiyo Nippon Sanso Corporation Basic Information List
Table Urenco Limited Basic Information List
Table Rotem Industries, Ltd., Inc. Basic Information List
Table Australian Nuclear Association And Technology Organization (ANSTO) Basic Information List
Table Board of Radiation And Isotope Technology (BRIT) Basic Information List
Table Institute of Atomic Energy Polatom Radioisotope Centre Basic Information List
Table Institute of Isotopes Co., Ltd. Basic Information List
Table Institute Of Radioelement (IRE) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Players/Suppliers in 2016
Table Major Buyers of Radiopharmaceuticals in Nuclear Medicine
Table Distributors/Traders List
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Type in 2022
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Application in 2022
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories